Recombinant long-acting glyco PEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials. - Negrier, C.; Young, G.; Abdul Karim, F.; Collins, P. W.; Hanabusa, H.; Colberg, T.; Goldman, B.; Walsh, C. E. (Haemophilia, 2016)